NeoVac Email Format
Biotechnology ResearchEngland, United Kingdom11-50 Employees
NeoVac is a clinical-stage company creating a revolutionary, unique and proprietary next-generation lipid nanoparticles platform to enable better RNA vaccines and medicines for various diseases. Allowing more people around the world access to better and more potent vaccines, using cutting-edge technology that makes RNA vaccines more transportable, with broader capabilities and fewer side effects.